Broad versus narrow clinical practice guidelines: avoiding rules for the high risk 1%

Harikumar, V., Worley, B., Ibrahim, S. A., Kang, B. Y., Maher, I. A., Cartee, T. V., Sobanko, J. F., Kibbi, N., Owen, J. L., Reynolds, K. A., Bolotin, D., Waldman, A. H., Minkis, K., Petersen, B., Council, M. L., Nehal, K. S., Xu, Y. G., Jiang, S. B., Somani, A.-K., … Alam, M. (2020). Broad versus narrow clinical practice guidelines: avoiding rules for the high risk 1%. Archives of Dermatological Research, 314(4), 385–387. https://doi.org/10.1007/s00403-020-02160-4
Authors:
Vishnu Harikumar
Brandon Worley
Sarah A. Ibrahim
Bianca Y. Kang
Ian A. Maher
Todd V. Cartee
Joseph F. Sobanko
Nour Kibbi
Joshua L. Owen
Kelly A. Reynolds
Diana Bolotin
Abigail H. Waldman
Kira Minkis
Brian Petersen
M. Laurin Council
Kishwer S. Nehal
Y. Gloria Xu
S. Brian Jiang
Ally-Khan Somani
Conway C. Huang
Daniel B. Eisen
David M. Ozog
Erica H. Lee
Faramarz H. Samie
Isaac M. Neuhaus
Justin J. Leitenberger
Margaret W. Mann
Naomi Lawrence
Nathalie C. Zeitouni
Nicholas Golda
Ramona Behshad
Sherrif F. Ibrahim
Siegrid S. Yu
Thuzar M. Shin
William G. Stebbins
Murad Alam
Affiliated Authors:
Faramarz H. Samie
Author Keywords:
cancer
clinical practice
evidence-based medicine
guidelines
high risk
Publication Type:
Article
Unique ID:
10.1007/s00403-020-02160-4
PMID:
Publication Date:
Data Source:
Scopus

Record Created: